The Board of OncoSil Medical Ltd. announced the appointment of Mr. Otto Buttula to the OncoSil Board as a Non-Executive Director effective 20 July 2021. Mr. Buttula is a prominent biotech investor and has more than 30 years of experience in investment research, funds management and information technology. Dr. Chris Roberts and Mr. Michael Bassett intend to step down from the Board at the time of OncoSil's Annual General Meeting, expected to be held in October 2021. Chris and Michael will work closely with the OncoSil Board to ensure a smooth transition during this period. Upon the departure of Dr. Chris Roberts from the Board, it is expected that Mr. Buttula will be elected Chairman.